Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Warner Chilcott Ovcon 35 Launch Delayed By Bristol Manufacturing

This article was originally published in The Pink Sheet Daily

Executive Summary

This is the second launch delay for the chewable oral contraceptive. Warner Chilcott expects to transfer manufacturing of Ovcon from Bristol to a recently-acquired Pfizer plant.

You may also be interested in...



Barr Will Launch Generic Ovcon 35 In October After Regaining Rights To ANDA

Under pressure from FTC, Warner Chilcott ends an exclusive agreement which was blocking Barr entry until May 2009.

Barr Will Launch Generic Ovcon 35 In October After Regaining Rights To ANDA

Under pressure from FTC, Warner Chilcott ends an exclusive agreement which was blocking Barr entry until May 2009.

FTC, States Sue Barr, Warner Chilcott Over Ovcon-35 Deal

Lawsuit claims companies' agreement regarding generic Ovcon-35 was anti-competitive.

Related Content

Topics

UsernamePublicRestriction

Register

ID1131437

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel